Proteomics

Dataset Information

0

Murine BM neutrophil WT vs KI experiment 1


ABSTRACT: Murine neutrophils derived from bone marrow of wild-type and cPLA2alpha-knockin mice (with the C1P interaction site of cPLA2alpha ablated) proteomes were compared

INSTRUMENT(S): Q Exactive HF

ORGANISM(S): Mus Musculus (mouse)

TISSUE(S): Neutrophil, Bone Marrow

DISEASE(S): Wounds And Injuries

SUBMITTER: Kenneth Maus  

LAB HEAD: Charles Edward Chalfant

PROVIDER: PXD039415 | Pride | 2023-10-24

REPOSITORIES: Pride

Dataset's files

Source:
Action DRS
20191220_Kenny_Neutrophils-1.raw Raw
20191220_Kenny_Neutrophils-2.raw Raw
20191220_Kenny_Neutrophils-3.raw Raw
20191220_Kenny_Neutrophils-4.raw Raw
20191220_Kenny_Neutrophils-5.raw Raw
Items per page:
1 - 5 of 11
altmetric image

Publications

Skewing cPLA<sub>2</sub>α activity toward oxoeicosanoid production promotes neutrophil N2 polarization, wound healing, and the response to sepsis.

Maus Kenneth D KD   Stephenson Daniel J DJ   Macknight H Patrick HP   Vu Ngoc T NT   Hoeferlin L Alexis LA   Kim Minjung M   Diegelmann Robert F RF   Xie Xiujie X   Chalfant Charles E CE  

Science signaling 20230711 793


Uncontrolled inflammation is linked to poor outcomes in sepsis and wound healing, both of which proceed through distinct inflammatory and resolution phases. Eicosanoids are a class of bioactive lipids that recruit neutrophils and other innate immune cells. The interaction of ceramide 1-phosphate (C1P) with the eicosanoid biosynthetic enzyme cytosolic phospholipase A<sub>2</sub> (cPLA<sub>2</sub>) reduces the production of a subtype of eicosanoids called oxoeicosanoids. We investigated the effect  ...[more]

Similar Datasets

2021-07-15 | PXD019342 | Pride
2010-01-26 | E-GEOD-20041 | biostudies-arrayexpress
2008-04-08 | E-GEOD-8845 | biostudies-arrayexpress
2016-03-08 | E-GEOD-77172 | biostudies-arrayexpress
2014-08-01 | E-MTAB-2802 | biostudies-arrayexpress
2021-09-09 | PXD019727 | Pride
2021-09-09 | PXD023345 | Pride
| S-EPMC8062736 | biostudies-literature
2022-09-15 | PXD035009 | Pride
2022-06-20 | PXD031041 | Pride